# Protara Therapeutics, Inc.: Form 8-K, filed Nov 19, 2025

- Company: [Protara Therapeutics, Inc.](/companies/tara.md) (CIK 1359931)
- Form: 8-K
- Filed: 2025-11-19
- Accepted by EDGAR: Nov 19, 2025, 09:15 ET
- Period: 2025-11-19
- Accession: 0001213900-25-112383
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1359931/000121390025112383/ea0266384-8k_protara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1359931/000121390025112383/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1359931/000121390025112383/ea0266384-8k_protara.htm

Filed Nov 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-112383. Last ingested by Listed: Nov 6, 2026, 12:14 ET. No prices; not investment advice.
